Table 2.
Patient characteristics – Validation cohort.
| Characteristic | STEMI | UAP | SAP | p |
|---|---|---|---|---|
| Sample size | 8 | 8 | 8 | |
| Age | 65.5 (9.9) | 64.0 (8.2) | 65.9 (8.1) | 0.90* |
| Male sex (n [%]) | 7 (87.5) | 6 (75.0) | 6 (75.0) | 0.78** |
| Troponin T (ng/ul) | 139.3 (118.2) | 55.6 (100.1) | 2.8 (0.6) | 0.02* |
| CRP (mg/l) | 21.9 (49.9) | 6.9 (2.1) | 19.7 (24.1) | 0.61* |
| Creatinine | 83.8 (15.7) | 99.0 (44.5) | 90.3 (32.2) | 0.43* |
| Total Cholesterol (mM) | 5.2 (1.3) | 5.2 (1.5) | 4.2 (0.8) | 0.19* |
| HDL (mM) | 1.1 (0.2) | 1.2 (0.3) | 1.4 (0.5) | 0.25* |
| LDL (mM) | 3.2 (0.9) | 3.3 (1.3) | 2.0 (0.9) | 0.04* |
Information of participants included in the validation cohort. Continuous variables are presented as mean and standard deviation. CRP, C-reactive protein; HDL, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol. *Determined with one-way ANOVA. **Determined with Chi-Square and Fisher’s exact test.